Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka, 573-0101, Japan.
Pharm Res. 2012 Jun;29(6):1485-94. doi: 10.1007/s11095-011-0623-2. Epub 2011 Dec 2.
The aim of the present study is to evaluate the formulation effect on the oral absorption of poorly water-soluble drugs using a dissolution/permeation system (D/P system).
This D/P system, consisting of apical and basal chambers and a Caco-2 cell monolayer mounted between chambers, can be used to perform simultaneous analysis of drug dissolution and permeation process of drugs applied as various dosage forms. Oral administration study with rats was also performed for both drugs as the same dosage forms.
When danazol, a low-soluble and high-permeable drug, was applied to the D/P system as various formulations, dissolved and permeated amounts were significantly high compared with those from a suspension form. On the other hand, whereas the dissolved amount of pranlukast, a low-soluble and low-permeable drug, was significantly increased by formulations, there were no significant changes observed in the permeated amount between suspension and formulation. The oral availability of danazol was significantly increased by formulations but not pranlukast, which corresponded well to in vitro evaluations.
These results indicated that the D/P system might be applicable for selection of formulation on the basis of physicochemical drug properties.
本研究旨在使用溶解/渗透系统(D/P 系统)评估制剂对亲水性差的药物口服吸收的影响。
该 D/P 系统由顶室和底室以及置于室之间的 Caco-2 细胞单层组成,可用于同时分析各种剂型药物的溶解和渗透过程。还对两种药物以相同剂型进行了大鼠口服给药研究。
当将低溶解度和高渗透性的药物达那唑作为各种制剂应用于 D/P 系统时,与混悬剂相比,溶解和渗透的量显著增加。另一方面,尽管普拉洛芬的溶解度通过制剂显著增加,但混悬剂和制剂之间的渗透量没有显著变化。达那唑的口服生物利用度通过制剂显著提高,但普拉洛芬没有,这与体外评价结果相符。
这些结果表明,D/P 系统可能适用于基于药物物理化学性质选择制剂。